Clofarabine monotherapy in two patients with refractory Langerhans cell histiocytosis

BACKGROUND: Better therapeutic options other than conventional chemotherapy for pediatric patients with refractory Langerhans cell histiocytosis (LCH) remain undetermined. CASE: We successfully treated two patients with refractory and risk organ negative LCH with clofarabine (CLO) monotherapy after...

Descripción completa

Detalles Bibliográficos
Autores principales: Irie, Masahiro, Nakano, Tomohiro, Katayama, Saori, Suzuki, Tasuku, Moriya, Kunihiko, Watanabe, Yuko, Suzuki, Nobu, Saitoh‐Nanjyo, Yuka, Onuma, Masaei, Rikiishi, Takeshi, Niizuma, Hidetaka, Sasahara, Yoji, Kure, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351665/
https://www.ncbi.nlm.nih.gov/pubmed/34725963
http://dx.doi.org/10.1002/cnr2.1579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351665/
https://www.ncbi.nlm.nih.gov/pubmed/34725963
http://dx.doi.org/10.1002/cnr2.1579

Ejemplares similares